Skip to main content
Canna~Fangled Abstracts

Anticonvulsive Properties of Cannabidiol in a Model of Generalized Seizure Are Transient Receptor Potential Vanilloid 1 Dependent

By June 1, 2020July 14th, 2020No Comments
. 2020 Jun 5;5(2):145-149.

doi: 10.1089/can.2019.0028.eCollection 2020 Jun 1.

Royston A Gray 1, Colin G Stott 2, Nicholas A Jones 1, Vincenzo Di Marzo 3 4, Benjamin J Whalley 1 5
Affiliations

Abstract

Introduction: Highly purified cannabidiol (CBD) (approved as Epidiolex® in the United States) has demonstrated efficacy with an acceptable safety profile in patients with Lennox-Gastaut or Dravet syndrome in four randomized controlled trials. CBD possesses affinity for many target classes with functional effects relevant to the pathophysiology of many disease types, including epilepsy. Although the mechanism of action of CBD underlying the reduction of seizures in humans is unknown, transient receptor potential vanilloid 1 (TRPV1) represents a plausible target because (1) CBD activates and then desensitizes TRPV1, (2) TRPV1 is overexpressed in models of temporal lobe epilepsy and patients with epilepsy, (3) and TRPV1 modulates neuronal excitability.

Methods: To investigate a potential role of TRPV1 in the anticonvulsive effects of CBD, the effect of CBD on seizure threshold was assessed using a mouse maximal electroshock threshold model of generalized seizure in TRPV1 knockout and wildtype mice. The dose dependence of the CBD effect was determined and compared with that of the positive comparator diazepam and vehicle.

Results:At 50 and 100 mg/kg, CBD significantly (p<0.0001) increased seizure threshold in wildtype mice compared with TRPV1 knockout and vehicle controls. This effect was observed only at 100 mg/kg in TRPV1 knockout mice compared with knockout vehicle mice, in which gene deletion partially attenuated the CBD-increased seizure threshold. The effect of high-dose CBD in wildtype mice was nevertheless significantly different from vehicle-treated TRPV1 knockout mice (p<0.0001). Bioanalysis confirmed that genotype-specific differential brain exposure to CBD was not responsible for the observed effect on seizure threshold.

Conclusion: These data strongly implicate TRPV1 in the potential mechanisms of action for the anticonvulsive effects of CBD. The partial inhibition of the anticonvulsive effect of high-dose CBD in TRPV1 knockout mice may indicate the involvement of targets other than TRPV1. Further characterization of TRPV1 in the anticonvulsive effect of CBD in validated models of seizure is warranted, as is pharmacological investigation of the molecular interaction between CBD and TRPV1.

 

Keywords: CBD, TRPV1, anticonvulsant, epilepsy, mechanism of action, seizures

Conflict of interest statement

All authors met the ICMJE authorship criteria. Neither honoraria nor payments were made for authorship. R.A.G., C.G.S., N.A.J., and B.J.W. are employees of GW Research Ltd. and stock shareholders of GW Pharmaceuticals plc. V.D.M. receives research grants from, and is a consultant for, GW Research Ltd.

Figures

FIG. 1.

FIG. 2.

 

References

    1. Rosenbaum T, Simon SA. TRPV1 receptors and signal transduction. In: Liedtke WB, Heller S, eds. TRP Ion Channel Function in Sensory Transduction and Cellular Signaling Cascades. CRC Press/Taylor & Francis Group, LLC: Boca Raton, FL, 2007
    1. De Petrocellis L, Ligresti A, Moriello AS, et al. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. Br J Pharmacol. 2011;163:1479–1494 – PMC – PubMed
    1. Caterina MJ. TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation. ACS Chem Neurosci. 2014;5:1107–1116 – PMC – PubMed
    1. Vay L, Gu C, McNaughton PA. The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol. 2012;165:787–801 – PMC – PubMed
    1. Menigoz A, Boudes M. The expression pattern of TRPV1 in brain. J Neurosci. 2011;31:13025–13027 – PMC – PubMed

Leave a Reply